GSTM1 Null, GSTT1 Null, and GSTM1/GSTT1 Null Genotypes in Healthy Controls and in ALL Patients
| Genotype . | No. (%) . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Whites . | Blacks . | . | . | . | . | ||||
| . | Male . | Female . | Total . | Male . | Female . | Total . | . | . | . | . |
| GSTM1 null | ||||||||||
| Control | 55/111 (49.5) | 59/102 (57.8) | 114/213 (53.5) | 23/103 (22.3) | 33/100 (33.0) | 56/203 (27.6) | ||||
| ALL | 43/85 (50.6) | 47/78 (60.3) | 90/163 (55.2) | 10/22 (45.5) | 4/12 (33.3) | 14/34 (41.2) | ||||
| GSTT1 null | ||||||||||
| Control | 17/111 (15.3) | 15/102 (14.7) | 32/213 (15.0) | 28/103 (27.2) | 21/100 (21.0) | 49/203 (24.1) | ||||
| ALL | 14/85 (16.5) | 9/78 (11.5) | 23/163 (14.1) | 8/22 (36.4) | 4/12 (33.3) | 12/34 (35.3) | ||||
| GSTM1 null + GSTT1 null | ||||||||||
| Control | 10/111 (9.0) | 7/102 (6.9) | 17/213 (8.0) | 4/103 (3.9) | 4/100 (4.0) | 8/203 (3.9) | ||||
| ALL | 5/85 (5.9) | 5/78 (6.4) | 10/163 (6.1) | 5/22 (22.7) | 3/12 (25.0) | 8/34 (23.5) | ||||
| Genotype . | No. (%) . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Whites . | Blacks . | . | . | . | . | ||||
| . | Male . | Female . | Total . | Male . | Female . | Total . | . | . | . | . |
| GSTM1 null | ||||||||||
| Control | 55/111 (49.5) | 59/102 (57.8) | 114/213 (53.5) | 23/103 (22.3) | 33/100 (33.0) | 56/203 (27.6) | ||||
| ALL | 43/85 (50.6) | 47/78 (60.3) | 90/163 (55.2) | 10/22 (45.5) | 4/12 (33.3) | 14/34 (41.2) | ||||
| GSTT1 null | ||||||||||
| Control | 17/111 (15.3) | 15/102 (14.7) | 32/213 (15.0) | 28/103 (27.2) | 21/100 (21.0) | 49/203 (24.1) | ||||
| ALL | 14/85 (16.5) | 9/78 (11.5) | 23/163 (14.1) | 8/22 (36.4) | 4/12 (33.3) | 12/34 (35.3) | ||||
| GSTM1 null + GSTT1 null | ||||||||||
| Control | 10/111 (9.0) | 7/102 (6.9) | 17/213 (8.0) | 4/103 (3.9) | 4/100 (4.0) | 8/203 (3.9) | ||||
| ALL | 5/85 (5.9) | 5/78 (6.4) | 10/163 (6.1) | 5/22 (22.7) | 3/12 (25.0) | 8/34 (23.5) | ||||